ストックスクリーナーアプリを入手
3.88
9.35%
-0.40
前日終値:
$4.28
開ける：
$4.3
24時間の取引高:
4.88M
Relative Volume:
0.93
時価総額：
$371.82M
収益：
当期純損益:
$-75.43M
株価収益率:
-3.1801
EPS:
-1.2201
ネットキャッシュフロー:
$-72.75M
1週間 パフォーマンス:
-3.00%
1か月 パフォーマンス:
-15.84%
6か月 パフォーマンス:
-32.05%
1年 パフォーマンス:
+13.12%
1日の値動き範囲:
$3.86
$4.35
1週間の範囲:
$3.85
$4.78
52週間の値動き範囲:
$3.15
$7.44
Zura Bio Ltd Stock (ZURA) Company Profile
Compare ZURA vs VRTX, MRNA, REGN, ARGX, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ZURA
Zura Bio Ltd
|
3.88 | 371.82M | 0 | -75.43M | -72.75M | -1.2201 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Zura Bio Ltd Stock (ZURA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-07-08 | 開始されました | William Blair | Outperform |
| 2026-02-09 | 開始されました | Wedbush | Outperform |
| 2024-11-04 | 開始されました | Leerink Partners | Outperform |
| 2024-09-05 | 開始されました | H.C. Wainwright | Neutral |
| 2024-05-03 | 開始されました | Piper Sandler | Overweight |
| 2023-10-10 | 開始されました | Ladenburg Thalmann | Buy |
| 2023-08-25 | 開始されました | Oppenheimer | Outperform |
| 2023-06-22 | 開始されました | Guggenheim | Buy |
| 2023-06-14 | 開始されました | Chardan Capital Markets | Buy |
| 2023-05-24 | 開始されました | Raymond James | Strong Buy |
すべてを表示
Zura Bio Ltd (ZURA) 最新ニュース
Zura Bio (ZURA) Hits Enrollment Milestones As Losses Widen Sharply - Yahoo Finance
Zura Bio at 12th annual cantor fitzgerald global healthcare conference: data ahead - Investing.com Nigeria
Zura Bio at 12th annual cantor fitzgerald global healthcare conference: data ahead By Investing.com - Investing.com South Africa
Zura Bio at 12th annual cantor fitzgerald global healthcare conference: data ahead - Investing.com Canada
Zura Bio at 12th annual cantor fitzgerald global healthcare conference: data ahead - Investing.com India
CABA Stock Price and Chart — NASDAQ:CABA - TradingView
Zura Bio to Participate in the Cantor Global Healthcare Conference - Yahoo Finance
This Zura Bio Insider Increased Their Holding In The Last Year - simplywall.st
Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Zura Bio (NASDAQ: ZURA) director plans 50,000-share sale after prior trades - Stock Titan
Zura Bio (NASDAQ: ZURA) affiliate plans stock sale via option exercise - Stock Titan
Zura Bio Releases Updated Corporate Presentation in Latest SEC Filing - Kalkine Media
Zura Bio updates corporate presentation; HS Phase 2 topline Q4 2026, SSc readout H1 2027, cash runway through 2028 - TradingView
Zura Bio Limited (NASDAQ:ZURA) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
ZURA (ZURA) insider Someit Sidhu plans 40,000-share sale after option exercise - Stock Titan
Zura Bio Ltd SEC Filing (Aug 13, 2026) - Stock Titan
Wedbush Maintains Zura Bio(ZURA.US) With Buy Rating, Raises Target Price to $22 - Moomoo
Zura Bio Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Guggenheim raises Zura Bio stock price target on new drug indication - Investing.com
Guggenheim raises Zura Bio stock price target on new drug indication - Investing.com India
Guggenheim raises Zura Bio stock price target on new drug indication - Investing.com
Zura Bio Submits Q2 2026 SEC Report Highlighting Financial and Operational Status - Kalkine Media
Zura Bio Q2 Results: EPS Misses Estimate as Losses Widen 23.53% YoY - scanx.trade
Zura Bio Limited Reports Q2 2026 Financial Results and Updates Investor Presentation in 8-K Filing - Kalkine Media
Form 8K Zura Bio Limited For: 11 August By Investing.com - Investing.com Nigeria
Form 8K Zura Bio Limited For: 11 August By Investing.com - Investing.com South Africa
Form 8K Zura Bio Limited For: 11 August By Investing.com - Investing.com Canada
Zura Bio Ltd 2Q 2026: Net loss $(26.3)M, EPS $(0.21) — 10-Q Summary - TradingView
Financial update and recent changes drive Zura Bio performance - Traders Union
Zura Bio Completes Enrollment in 247-Participant Hidradenitis Study - Stock Titan
Zura Bio Reports Second Quarter 2026 Financial Results and Recent Corporate Updates - Yahoo Finance
Zura Bio Ltd expected to post a loss of 20 cents a shareEarnings Preview - TradingView
Zura Bio Ltd (ZURA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Zura Bio (ZURA) Projected to Announce Earnings on Thursday - MarketBeat
1,179,715 Shares in Zura Bio Limited $ZURA Purchased by EcoR1 Capital LLC - MarketBeat
Zura Bio Ltd (ZURA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Zura Bio Ltd (ZURA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Zura Bio Ltd (ZURA) Cash Flow - TradingKey
Zura Bio Ltd (ZURA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Zura Bio Ltd (ZURA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ZURA|Zura Bio Ltd|Price:5.230|Chg%:-0.060 - TradingKey
Zura Bio Ltd (ZURA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Zura Bio Ltd (ZURA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
ZURA|Zura Bio Ltd|Price:5.240|Chg%:-0.140 - TradingKey
TradingKey - TradingKey
Marlyn Teresa Mathew Net Worth (2026) - GuruFocus
William Blair Starts Zura Bio (ZURA) at Outperform - Yahoo Finance
ZURA Initiated Coverage by William Blair -- Rating Set to Outper - GuruFocus
Zura Bio Ltd (ZURA) 財務データ
収益
当期純利益
現金流量
EPS
Zura Bio Ltd (ZURA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| SOMEIT SIDHU | Director |
Aug 17 '26 |
Proposed Sale |
5.61 |
27,000 |
151,343 |
0 |
| SOMEIT SIDHU | Director |
Aug 14 '26 |
Proposed Sale |
5.51 |
40,000 |
220,540 |
0 |
| SOMEIT SIDHU | Director |
Aug 13 '26 |
Proposed Sale |
5.63 |
51,000 |
287,043 |
0 |
| AI Biotechnology LLC | 10% Owner |
Feb 26 '26 |
Buy |
6.25 |
2,000,000 |
12,500,000 |
6,552,725 |
4.22%
大文字化:
|
ボリューム (24 時間):